Published in AIDS Weekly, March 26th, 2001
Clinical trials have confirmed the extensive HIV inhibiting ability of chloroquine and its derivatives, A. Savarino and colleagues reported in the Journal of Clinical Virology. Because these drugs have already seen extensive use, their toxicity profiles are well known. HIV inhibition was found at doses well within the safe range, the researchers added.
Multiple HIV strains are susceptible to chloroquine inhibition, according to their report,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.